Related Experiment Video
Updated: Jun 10, 2026

12:34
Robot-Assisted Radical Antegrade Modular Pancreatosplenectomy Including Resection and Reconstruction of the Spleno-Mesenteric Junction
Published on: January 3, 2020
Radical surgery for pancreatic malignancy in the elderly.
1Transplant Surgery Department, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. maol@medicon.cz
Summary
Older adults (65+) can safely undergo pancreatic cancer surgery. Patient fitness, not just age, determines surgical candidacy and outcomes, with acceptable morbidity and mortality rates.
Area of Science:
- Oncology
- Surgical Gastroenterology
- Geriatric Surgery
Background:
- Increasing life expectancy correlates with a higher incidence of pancreatic cancer.
- Pancreatic cancer surgery in elderly patients (65+) is a growing clinical concern.
- This study evaluates surgical outcomes in this specific demographic.
Purpose of the Study:
- To assess morbidity and mortality associated with curative-intent pancreatic surgery in patients aged 65 and older.
- To determine if advanced age is a contraindication for pancreatic cancer surgery.
- To identify factors influencing surgical outcomes in elderly pancreatic cancer patients.
Main Methods:
- Retrospective analysis of medical records from 2000-2007.
- Inclusion of 60 patients aged 65 years and older who underwent pancreatic surgery.
- Surgical procedures included hemipancreatoduodenectomy, distal pancreatectomy, and total pancreatectomy.
Main Results:
- Overall morbidity was 28%, with serious complications like pancreatic leaks occurring in 8% of patients.
- Thirty-day mortality was 6.6%, and 1-year survival reached 62.8%.
- The majority of patients (72%) underwent hemipancreatoduodenectomy, often combined with vessel resection.
Conclusions:
- Age alone is not a barrier to pancreatic cancer surgery.
- A patient's overall health status, comorbidities, and resilience to complications are critical factors.
- Careful patient selection is key for successful surgical outcomes in elderly individuals undergoing pancreatic cancer treatment.

